Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients

Background: Convalescent plasma is the only antibody based therapy currently available for COVID-19 patients. It has robust historical precedence and sound biological plausibility. Although promising, convalescent plasma has not yet been shown to be safe as a treatment for COVID-19. Methods: Thus, w...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:medRxiv
Κύριοι συγγραφείς: Joyner, Michael, Wright, R. Scott, Fairweather, DeLisa, Senefeld, Jonathon, Bruno, Katelyn, Klassen, Stephen, Carter, Rickey, Klompas, Allan, Wiggins, Chad, Shepherd, John RA, Rea, Robert, Whelan, Emily, Clayburn, Andrew, Spiegel, Matthew, Johnson, Patrick, Lesser, Elizabeth, Baker, Sarah, Larson, Kathryn, Ripoll Sanz, Juan, Andersen, Kylie, Hodge, David, Kunze, Katie, Buras, Matthew, Vogt, Matthew, Herasevich, Vitaly, Dennis, Joshua, Regimbal, Riley, Bauer, Philippe, Blair, Janis, van Buskirk, Camille, Winters, Jeffrey, Stubbs, James, Paneth, Nigel, Casadevall, Arturo
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Cold Spring Harbor Laboratory 2020
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7274247/
https://ncbi.nlm.nih.gov/pubmed/32511566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.05.12.20099879
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια